DreaMed Diabetes Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
36

- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.21M
- Investors
-
9
DreaMed Diabetes General Information
Description
Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses event-driven machine learning and logic technology in order to process multiple personalized parameters such as insulin delivery data, glucose readings, meal data, and optimized insulin dosing treatment plan, enabling clients to improve their living standards and down their overall treatment costs.
Contact Information
Website
www.dreamed-diabetes.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- 5 Mota Gur Street
- Petah Tikva 4952701
- Israel
DreaMed Diabetes Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC | 18-Sep-2017 | $1.21M | 00.000 | Completed | Generating Revenue | |
3. Early Stage VC (Series A) | 25-Jul-2016 | 00.00 | 00.00 | 000.00 | Completed | Generating Revenue |
2. Grant | 03-Feb-2016 | $3.4M | $2M | Completed | Generating Revenue | |
1. Angel (individual) | 06-Apr-2015 | $2M | $2M | 000.00 | Completed | Generating Revenue |
DreaMed Diabetes Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses even
Monitoring Equipment
Petah Tikva, Israel
36
As of 2022
00.000
0000000000 0
00.000
DreaMed Diabetes Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GlySens | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
00000000 00000000 | Venture Capital-Backed | Salem, NH | 000 | 00000 | 000000 - 000 | 00000 |
000000000 | Formerly Accelerator/Incubator backed | London, United Kingdom | 00 | 000000&0 | ||
0000000 0000000 | Private Equity-Backed | Fremont, CA | 00 | 00000 | 00000000 | 00000 |
0000 000000000000 | Corporation | Woodbridge Township, NJ | 00 | 000.00 | 000000000. 0 | 000.00 |
DreaMed Diabetes Patents
DreaMed Diabetes Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210193285-A1 | A system and method for use in disease treatment management | Pending | 19-Oct-2017 | 000000000 | |
AU-2010302266-A1 | Monitoring device for management of insulin delivery | Abandoned | 30-Sep-2009 | 000000000 | |
JP-2013526887-A | Monitoring device for insulin delivery | Granted | 30-Sep-2009 | 000000000 | 0 |
JP-5728767-B2 | Monitoring system, method and computer program for management of insulin delivery | Active | 30-Sep-2009 | 000000000 | |
CA-2776007-A1 | Monitoring device for mangement of insulin delivery | Abandoned | 30-Sep-2009 | G16H20/17 |
DreaMed Diabetes Executive Team (13)
DreaMed Diabetes Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Moshe Phillip | Self | Co-Founder, Chief Science Officer & Chairman | 000 0000 |
DreaMed Diabetes Signals
DreaMed Diabetes Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
A-Labs | Corporation | Minority | 000 0000 | 000000 0 | |
Mark Suss | Angel (individual) | Minority | 000 0000 | 000000 0 | |
OurCrowd | Venture Capital | Minority | 000 0000 | 000000 0 | |
Norma Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
The Millhouse | Asset Manager | Minority | 000 0000 | 000000 0 |